AU8499501A - Slo2 and slo4, novel potassium channel proteins from human brain - Google Patents
Slo2 and slo4, novel potassium channel proteins from human brainInfo
- Publication number
- AU8499501A AU8499501A AU8499501A AU8499501A AU8499501A AU 8499501 A AU8499501 A AU 8499501A AU 8499501 A AU8499501 A AU 8499501A AU 8499501 A AU8499501 A AU 8499501A AU 8499501 A AU8499501 A AU 8499501A
- Authority
- AU
- Australia
- Prior art keywords
- slo2
- potassium channel
- channel proteins
- slo4
- human brain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24911200P | 2000-11-15 | 2000-11-15 | |
| US09/921,159 US7041494B2 (en) | 2000-11-15 | 2001-08-01 | DNA encoding Slo2 and Slo4, potassium channel |
| PCT/US2001/025701 WO2002040649A1 (en) | 2000-11-15 | 2001-08-15 | Slo2 and slo4, novel potassium channel proteins from human brain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU8499501A true AU8499501A (en) | 2002-05-27 |
Family
ID=26939832
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU8499501A Pending AU8499501A (en) | 2000-11-15 | 2001-08-15 | Slo2 and slo4, novel potassium channel proteins from human brain |
| AU2001284995A Ceased AU2001284995B2 (en) | 2000-11-15 | 2001-08-15 | Slo2 and Slo4, novel potassium channel proteins from human brain |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001284995A Ceased AU2001284995B2 (en) | 2000-11-15 | 2001-08-15 | Slo2 and Slo4, novel potassium channel proteins from human brain |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US7041494B2 (https=) |
| EP (2) | EP1334178B1 (https=) |
| JP (1) | JP2005507633A (https=) |
| AT (1) | ATE525396T1 (https=) |
| AU (2) | AU8499501A (https=) |
| CA (1) | CA2428350A1 (https=) |
| WO (1) | WO2002040649A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1505150A1 (en) * | 2002-05-14 | 2005-02-09 | Takeda Pharmaceutical Company Limited | Novel proteins and dnas thereof |
| KR20230141862A (ko) * | 2021-02-08 | 2023-10-10 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | 담즙산염 박토센서 및 진단과 치료 목적을 위한 이들의 용도 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1112299A (en) * | 1997-10-22 | 1999-05-10 | Washington University | A ph sensitive potassium channel in spermatocytes |
| US20030143676A1 (en) * | 1999-03-25 | 2003-07-31 | Genesis Research And Development Corporation Limited | Fibroblast growth factor receptors and methods for their use |
| US6972187B2 (en) * | 2000-05-12 | 2005-12-06 | Millennium Pharmaceuticals, Inc. | OAT5 molecules and uses therefor |
| US20040009474A1 (en) * | 2000-05-24 | 2004-01-15 | Leach Martin D. | Novel human polynucleotides and polypeptides encoded thereby |
| US20020048787A1 (en) * | 2000-06-14 | 2002-04-25 | Ming-Hui Wei | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| JP2004533205A (ja) * | 2000-08-03 | 2004-11-04 | インサイト・ゲノミックス・インコーポレイテッド | 輸送体及びイオンチャネル |
| JP2005518185A (ja) * | 2001-06-04 | 2005-06-23 | キュラジェン コーポレイション | 新規タンパク質およびそれをコード化する核酸 |
-
2001
- 2001-08-01 US US09/921,159 patent/US7041494B2/en not_active Expired - Fee Related
- 2001-08-15 CA CA002428350A patent/CA2428350A1/en not_active Abandoned
- 2001-08-15 EP EP01964104A patent/EP1334178B1/en not_active Expired - Lifetime
- 2001-08-15 JP JP2002543646A patent/JP2005507633A/ja active Pending
- 2001-08-15 EP EP10176436A patent/EP2295454A1/en not_active Withdrawn
- 2001-08-15 AT AT01964104T patent/ATE525396T1/de not_active IP Right Cessation
- 2001-08-15 AU AU8499501A patent/AU8499501A/xx active Pending
- 2001-08-15 AU AU2001284995A patent/AU2001284995B2/en not_active Ceased
- 2001-08-15 WO PCT/US2001/025701 patent/WO2002040649A1/en not_active Ceased
-
2006
- 2006-01-04 US US11/325,764 patent/US7411043B2/en not_active Expired - Fee Related
-
2008
- 2008-07-22 US US12/177,819 patent/US7767450B2/en not_active Expired - Fee Related
-
2010
- 2010-03-09 US US12/720,461 patent/US7893209B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7893209B2 (en) | 2011-02-22 |
| WO2002040649A1 (en) | 2002-05-23 |
| US20060099640A1 (en) | 2006-05-11 |
| US20100267930A1 (en) | 2010-10-21 |
| JP2005507633A (ja) | 2005-03-24 |
| US7041494B2 (en) | 2006-05-09 |
| EP1334178B1 (en) | 2011-09-21 |
| CA2428350A1 (en) | 2002-05-23 |
| AU2001284995B2 (en) | 2007-03-29 |
| ATE525396T1 (de) | 2011-10-15 |
| US20090017534A1 (en) | 2009-01-15 |
| EP1334178A1 (en) | 2003-08-13 |
| EP1334178A4 (en) | 2006-03-29 |
| US7767450B2 (en) | 2010-08-03 |
| WO2002040649A8 (en) | 2002-11-07 |
| EP2295454A1 (en) | 2011-03-16 |
| US7411043B2 (en) | 2008-08-12 |
| US20030017533A1 (en) | 2003-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02011656A (es) | Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos. | |
| EP1124846A4 (en) | NOGO GENE NUCLEOTIDE AND PROTEIN SEQUENCES AND METHODS BASED ON SUCH SEQUENCES | |
| NZ270659A (en) | Mammalian protein which binds to a gst-fkbp-rapamycin complex, dna therefor and diagnostic compositions | |
| AU2001294541A1 (en) | Mammalian genes; related reagents and methods | |
| DE69833014D1 (de) | Menschliche toll homologen | |
| WO2003020932A1 (en) | Novel secretory proteins and dna thereof | |
| WO1995006735A3 (en) | Nucleotide sequences for novel protein tyrosine phosphatases | |
| EP1897949A3 (en) | Human interleukin-B50. Therapeutic uses | |
| EP1183330A4 (en) | KV10, A NEW POTASSICAL CHANNEL CONTROLED BY VOLTAGE FROM A HUMAN BRAIN | |
| WO1998023750A3 (en) | Mammalian chemokines | |
| WO2002026929A3 (en) | Kini-3 motor protein and methods for its use | |
| AU8499501A (en) | Slo2 and slo4, novel potassium channel proteins from human brain | |
| WO2002034915A3 (en) | Preferred segments of neural thread protein and methods of using the same | |
| WO2001096593A3 (en) | Novel motor proteins and methods for their use | |
| WO2002012541A3 (en) | Novel motor proteins and methods for their use | |
| WO2002033084A3 (en) | Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family | |
| WO2002062964A3 (en) | Ap1 amine oxidase variants | |
| EP0816498A3 (en) | Excitatory amino acid receptor protein and related nucleic acid compounds | |
| WO2002079479A3 (en) | Motor proteins and methods for their use | |
| WO2001087932A3 (en) | Seven transmembrane proteins and polynucleotides encoding the same | |
| WO2003004678A3 (en) | Novel receptors | |
| WO2001094417A3 (en) | Novel human seven transmembrane proteins and polynucleotides encoding the same | |
| WO2003012120A3 (en) | Lp354 mammalian secreted protein | |
| WO2001098314A3 (en) | Novel motor proteins and methods for their use | |
| WO2003048320A3 (en) | Novel motor protein of p. falciparum and methods for its use |